Recent study has shown that topoisomerase IIβ downregulation may cause neurodegeneration through dysregulation of Rho-GTPases leading to PD-like pathology, which may be a potential direction in the prevention and treatment of PD in the future 150. Here, TOP2B is linked to Parkinson disease.